By Jillian J. Jordan, et al. Abstract COVID-19 prevention behaviors may be seen as self-interested or prosocial. Using American samples from MTurk and Prolific (total n = 6850), we investigated which framing is more effective—and motivation is stronger—for...
By Michel C. Nussenzweig, Senior Physician, Investigator, Howard Hughes Medical Institute, Zanvil A. Cohn and Ralph M. Steinman Professor, Laboratory of Molecular Immunology This news story (August 24 2021) has been updated to reflect the publication on October 7,...
By Jack M. Lawrence et al. To the Editor — The global demand for prophylactic and treatment options for COVID-19 has in turn created a demand for both randomized clinical trials, and the synthesis of those trials into meta-analyses by systematic review. This...
As debates about booster shots heat up, what’s known about the duration of vaccine-based immunity is still evolving. By Elie Dolgin Six months ago, Miles Davenport and his colleagues made a bold prediction. On the basis of published results from vaccine trials and...
A preliminary analysis of viral genomes suggests the COVID-19 pandemic might have multiple animal origins — but the findings still have to be peer reviewed. By Smriti Mallapaty SARS-CoV-2, the virus that causes COVID-19, could have spilled from animals to people...
Hundreds of scientists had worked on mRNA vaccines for decades before the coronavirus pandemic brought a breakthrough. By Elie Dolgin In late 1987, Robert Malone performed a landmark experiment. He mixed strands of messenger RNA with droplets of fat, to create a kind...
By Francesco Fuso Nerini Originally published August 12, 2021 Abstract Here we discuss how personal carbon allowances (PCAs) could play a role in achieving ambitious climate mitigation targets. We argue that recent advances in AI for sustainable development, together...
Massive UK study of COVID-19 cases shows that people who are jabbed have good immunity at first, but quickly become more vulnerable to the fast-spreading Delta variant. By Katharine Sanderson The Pfizer–BioNTech and Oxford–AstraZeneca COVID-19 vaccines are effective...
Real-world evidence from a medical centre links high levels of potent antibodies after vaccination to a reduced risk of infection. By Smriti Mallapaty People fully vaccinated against COVID-19 are less likely to become infected with the coronavirus if they have...
May 26, 2021 ~ Nature ~ Lewis Au, et al. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2 Abstract Patients with cancer are currently prioritized in coronavirus disease 2019 (COVID-19) vaccination programs globally, which...
https://www.nature.com/articles/s41591-021-01318-5 Originally published by: Nature Author: Delphine Planas, Date: 3/26/2021 Categories: Integrative Therapies,Prevention,Vaccines
https://www.nature.com/articles/s42255-021-00347-1 Originally published by: Nature Author: Janis A. Müller et al. Date: 2/3/2021 Categories: Integrative Therapies,Recovery,Long Haul